Skip to content
BIOPHARMACEUTICAL

Scaling SaaS and Services Operations In Biopharma: AccessSync’s Growth Through Digital Boost 3.0

CYBER, DATA, AI
January 28, 2026

Challenges

  • Rapid growth influenced existing processes and scalability
  • Complex data assets drove new requirements
  • AI adoption as an emerging technology in a highly regulated and complex industry

Services provided

  • Data and asset assessment
  • Cybersecurity assessment
  • AI readiness and industry analysis

Results

  • Clear visibility into critical data assets
  • Cybersecurity opportunities assessment
  • Defined foundation for future AI adoption
Market Access Meets Digital Transformation

AccessSync is a fully integrated provider of Market Access Solutions in the biopharmaceutical sector, providing Software as a Service (SaaS) products and managed services to the sector. For over two decades, teams from market access, field sales, reimbursement, account management, and brand marketing have relied on the software tools developed by the AccessSync team to achieve their commercialization objectives.

The organization developed AccessSync One, a category leading market access software platform used by biopharma companies to overcome market access complexity so innovative products can reach more patients. Integrating market access data from leading providers, AccessSync One provides a unified view of the top market access opportunities, providing an easy way for field sales to execute targeted market access messaging to specific HCPs and their office staff.

AccessSync has been experiencing rapid growth, validating its differentiated position in the market. However, leadership recognized that sustaining this momentum would require changes within the organization.

We've been growing for some time now and recognized that we needed to operate differently in order to sustain this growth and protect the long‑term value of our platform and data assets.
— Brent MacDonald, COO at AccessSync

To support this transition, AccessSync joined Digital Boost 3.0, TechImpact’s digital transformation program for New Brunswick–based companies. Digital Boost 3.0 is a two-phased program, including a comprehensive assessment to determine current capabilities and identify opportunities in the areas of cybersecurity, data management, and artificial intelligence (AI). The second phase supports the implementation of solutions identified during the assessment phase. The program also helps to offset some of these costs while working with New Brunswick based technology providers.

Digital Boost 3.0 enabled AccessSync to partner with Second Spring Digital to conduct a comprehensive assessment and build a multi‑year digital and AI adoption roadmap.

Assessment Phase

Through Digital Boost, Second Spring Digital conducted a comprehensive assessment which includes data, cybersecurity, and AI assessments. The data assessment focused on identifying key data elements within AccessSync’s platform and supporting data stores.

The cybersecurity assessment combined insights from leadership interviews, data findings, and industry research to produce a quantified risk assessment aligned with pharmaceutical security, privacy, and compliance requirements. The AI assessment examined AccessSync’s use of AI and explored broader industry trends in the pharmaceutical market. The focus was on opportunities, regulatory constraints, data privacy concerns, and compliance considerations relevant to interactions between sales representatives, insurers, and prescribers.

Implementation Phase

Based on the assessment findings, Second Spring Digital worked with AccessSync to translate insights into a clear roadmap for action. Key efforts centered on data visibility and governance, data asset ownership, and aligning cybersecurity practices with the realities of operating in a highly regulated pharmaceutical environment. The AI assessment provided leadership with a realistic understanding of where AI could deliver value, where risks needed to be managed carefully, and how industry constraints should shape future decisions.

Our objective was not to drive immediate large‑scale deployments, but to build the right digital foundation to support sustainable growth, enterprise security, and future innovation. We focused on protecting AccessSync’s most valuable assets, reducing operational risk, and sequencing investments to maximize long‑term impact. 
— Scott MacIntosh, CEO of Second Spring Digital
The Results

Participating in the Digital Boost program enabled more efficient internal processes, reducing operational risk, and helped lay the groundwork for a stronger, more user-centered platform experience. With a solid digital foundation in place, AccessSync is better equipped to convert growth opportunities into long-term success while maintaining the trust, security, and compliance demanded by the pharmaceutical industry.

Compliance in a highly regulated industry is always top of mind for us and, this was a great opportunity to partner and explore program themes that are also top of mind for our customers. Following the project, we’ve continued building out our data and analytics practice and made key investments that resulted in an expanded team, new processes, and new tooling. 
— Brent MacDonald, COO at AccessSync
Digital Transformation Digital Boost Second Spring Digital AccessSync